Status of immune mediators in painful neuropathies
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Peripheral neuropathies of identical etiology can be painful or painless. The reason for this difference in clinical presentation is as yet unknown; however, immune mediators, particularly cytokines, may play a role. Cytokines are proteins that are produced by immune and nonimmune cells and are categorized as pro-and anti-inflammatory. The role of cytokines in the induction and maintenance of pain has been well established in animal models. Proinflammatory cytokines are mostly algesic, whereas anti-inflammatory cytokines have analgesic properties. Clinical research also gives evidence for the involvement of cytokines in painful and painless neuropathies. A proinflammatory cytokine profile seems to be associated with pain in peripheral neuropathies of different etiologies and in other painful disorders such as the complex regional pain syndrome. Specifically, an imbalance between pro-and anti-inflammatory cytokines may contribute to pain generation. A better understanding of the underlying pathophysiology may open new opportunities for the treatment of pain.
Supplementary Material (0)
- Michaelis M, Vogel C, Blenk KH, et al.: Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci 1998, 18:7581–7587.
- Üçeyler N, Sommer C: Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett 2008 (in press).
- Thacker MA, Clark AK, Marchand F, McMahon SB: Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007, 3:838–847. CrossRef
- Kleinschnitz C, Brinkhoff J, Zelenka M, et al.: The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol 2004, 1–2:77–83. CrossRef
- Taskinen HS, Olsson T, Bucht A, et al.: Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA. J Neuroimmunol 2000, 1:17–25. CrossRef
- Zelenka M, Schäfers M, Sommer C: Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 2005, 3:257–263. CrossRef
- Junger H, Sorkin LS: Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain 2000, 1–2:145–151. CrossRef
- Milligan ED, Langer SJ, Sloane EM, et al.: Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 2005, 8:2136–2148. CrossRef
- Wagner R, Janjigian M, Myers RR: Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 1998, 1:35–42. CrossRef
- Exley AR, Smith N, Winer JB: Tumour necrosis factor-alpha and other cytokines in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1994, 9:1118–1120.
- Maimone D, Annunziata P, Simone IL, et al.: Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1993, 1:55–61. CrossRef
- Kuntzer T, Radziwill AJ, Lettry-Trouillat R, et al.: Interferon-beta1a in chronic inflammatory demyelinating polyneuropathy. Neurology 1999, 6:1364–1365.
- Misawa S, Kuwabara S, Mori M, et al.: Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy. Neurology 2001, 5:666–669.
- Empl M, Renaud S, Erne B, et al.: TNF-alpha expression in painful and nonpainful neuropathies. Neurology 2001, 10:1371–1377.
- Mathey EK, Pollard JD, Armati PJ: TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 1999, 1:47–52. CrossRef
- Oka N, Akiguchi I, Kawasaki T, et al.: Tumor necrosis factor-alpha in peripheral nerve lesions. Acta Neuropathol 1998, 95:57–62. CrossRef
- Putzu GA, Figarella-Branger D, Bouvier-Labit C, et al.: Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre syndrome. J Neurol Sci 2000, 1:16–21. CrossRef
- Michalowska-Wender G, Adamcewicz G, Wender M: Impact of cytokines on the pathomechanism of diabetic and alcoholic neuropathies. Folia Neuropathol 2007, 2:78–81.
- Teles RM, Antunes SL, Jardim MR, et al.: Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients. J Peripher Nerv Syst 2007, 3:195–204. CrossRef
- Zhang J, Dong H, Li B, et al.: Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome. Eur Neurol 2007, 1:21–25. CrossRef
- Singer OC, Otto B, Steinmetz H, Ziemann U: Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy. Neurology 2004, 9:1754.
- Richez C, Blanco P, Lagueny A, et al.: Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology 2005, 8:1468–1470.
- Wallace DJ, Margolin K, Waller P: Fibromyalgia and interleukin-2 therapy for malignancy. Ann Intern Med 1988, 6:909.
- Watkins LR, Maier SF, Goehler LE: Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995, 3:289–302. CrossRef
- Barnes PF, Chatterjee D, Brennan PJ, et al.: Tumor necrosis factor production in patients with leprosy. Infect Immun 1992, 4:1441–1446.
- Gür A, Karakoç M, Erdogan S, et al.: Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 2002, 6:753–760.
- Üçeyler N, Valenza R, Stock M, et al.: Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 2006, 8:2656–2664. CrossRef
- Huygen FJ, De Bruijn AG, De Bruin MT, et al.: Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 2002, 1:47–51. CrossRef
- Üçeyler N, Eberle T, Rolke R, et al.: Differential expression patterns of cytokines in complex regional pain syndrome. Pain 2007, 1–2:195–205. CrossRef
- Brisby H, Olmarker K, Larsson K, et al.: Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J 2002, 1:62–66.
- Burke JG, Watson RW, McCormack D, et al.: Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc. Spine 2002, 13:1402–1407. CrossRef
- Kotani N, Kudo R, Sakurai Y, et al.: Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia. Am J Med 2004, 5:318–324. CrossRef
- Bernateck M, Rolke R, Birklein F, et al.: Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1. Anesth Analg 2007, 4:1148–1151, table of contents. CrossRef
- Huygen FJ, Niehof S, Zijlstra FJ, et al.: Successful treatment of CRPS 1 with anti-TNF. J Pain Symptom Manage 2004, 2:101–103. CrossRef
- Lindenlaub T, Sommer C: Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 2003, 6:593–602.
- Backonja MM, Coe CL, Muller DA, Schell K: Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol 2008 Mar 4 (Epub ahead of print).
- Ludwig J, Binder A, Schattschneider J, et al.: Cytokine expression in serum and cerebro-spinal fluid of patients with polyneuropathy. Der Schmerz 2007, 21(Suppl):109.
- Üçeyler N, Rogausch JP, Toyka KV, Sommer C: Differential expression of cytokines in painful and painless neuropathies. Neurology 2007, 69:42–49. CrossRef
- Hoitsma E, Faber CG, van Santen-Hoeufft M, et al.: Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:73–77.
- Üçeyler N, Kafke W, Toyka KV, Sommer C: Local and systemic cytokine expression in patients with small fiber neuropathy [abstract]. J Peripher Nerv Syst 2007, 12(Suppl 1):87.
- Wesseldijk F, Huygen FJ, Heijmans-Antonissen C, et al.: Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of complex regional pain syndrome type 1 in 66 patients. Eur J Pain 2007 Dec 3 (Epub ahead of print).
- Alexander GM, van Rijn MA, van Hilten JJ, et al.: Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 2005, 3:213–219. CrossRef
- Alexander GM, Perreault MJ, Reichenberger ER, Schwartzman RJ: Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome. Brain Behav Immun 2007, 5:668–676. CrossRef
- Schwartzman RJ, Chevlen E, Bengtson K: Thalidomide has activity in treating complex regional pain syndrome. Arch Intern Med 2003, 12:1487–1488; author reply 1488. CrossRef
- Manning DC: Immunomodulatory agents for neuropathic pain syndromes: from animals to CRPS and beyond. Eur J Pain 2006, 10(Suppl 1):S20. CrossRef
About this Article
- Status of immune mediators in painful neuropathies
Current Pain and Headache Reports
Volume 12, Issue 3 , pp 159-164
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links